Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Flat illustration of a cancer cell and in silico model

Jul 14, 2026

Biotech companies tout benefits of AI-assisted drug development

Biotechnology firms are increasingly integrating artificial intelligence (AI) into drug development processes, showcasing its potential to revolutionize research methodologies and outcomes. At the Kadans Oncology Summit in Paris, discussions highlighted various applications of AI, particularly in drug target discovery and the development of preclinical cancer models.One notable innovation is the use of in silico models, which aim to replace traditional cellular and animal testing methods. Paul D
AI agent prototype on a workbench

Jul 14, 2026

AMD Cloud Credits Support QwikAgents' Persistent AI Agents

Silo Pharma's subsidiary, QwikAgents, has joined the AMD AI Developer Program to enhance its AI agent platform.This collaboration grants QwikAgents access to AMD Developer Cloud credits and a suite of AI development tools aimed at accelerating the innovation of enterprise AI agents. Eric Weisblum, CEO of Silo Pharma, emphasized that these resources will facilitate the development, testing, and deployment of AI agents tailored for various applications, from content generation to workflow automati
A minimalist illustration of a dollar sign and stack of coins in a dark palette.

Jul 14, 2026

DeepSeek considers new funding round at $71B valuation, barely two months after raising $7B

DeepSeek, a Chinese AI startup, is reportedly exploring a new funding round that could value the company at around $71 billion, a significant increase from its previous valuation of $52 billion just six weeks ago.This rapid escalation in valuation highlights the intense investor interest in cost-effective open-source AI models. Since its inception, DeepSeek has seen its worth soar from an estimated $20 billion in April to its current valuation discussions, driven by a unique business model that
A test tube with a biological sample in a modern lab setting.

Jul 14, 2026

Lab of the Future Europe 2026

Lab of the Future Europe 2026 is poised to be a pivotal event for professionals at the intersection of biopharmaceutical research and technology. Scheduled for September 22-23, 2026, at the Beurs van Berlage in Amsterdam, this congress aims to unite over 600 leaders in the life sciences sector. Participants will engage in discussions centered on real-world applications and innovative strategies that leverage AI and digital technologies to enhance research and development. The agenda features mor
A hand holding a circuit board in a workspace

Jul 14, 2026

Silo Pharma’s QwikAgents Accepted Into AMD AI Developer Program

Silo Pharma's subsidiary, QwikAgents, has recently joined the AMD AI Developer Program, marking a significant advancement in its mission to develop AI-driven solutions for various users, including enterprises and individuals.Through this collaboration, QwikAgents gains access to AMD's Developer Cloud, which offers advanced AI tools, training resources, and a supportive global community. This integration is expected to enhance QwikAgents' platform, enabling the development of persistent AI agents
A minimalist illustration of a stethoscope and computer chip representing healthcare technology.

Jul 14, 2026

How AI-Powered Healthcare Software Development Services Are Transforming U.S. Healthcare in 2026

The U.S. healthcare landscape is rapidly evolving, driven by the adoption of AI and digital technologies. By 2026, healthcare providers are prioritizing custom software development to enhance patient care and streamline operations.As healthcare organizations seek to modernize, the demand for tailored software solutions is on the rise. Generic software often fails to meet the unique needs of various healthcare settings, prompting many to collaborate with specialized development firms. Custom appl
A minimalist illustration of a data network in a dark color scheme.

Jul 14, 2026

IQVIA’s New Direction: Building The Healthcare-Grade, AI-Ready Information Ecosystem Life Sciences Needs Now

IQVIA is pioneering a healthcare-grade information ecosystem designed to enhance the effectiveness of AI in the life sciences sector. This initiative addresses the critical need for a robust data foundation that supports advanced analytics and enterprise-level decision-making.As AI continues to transform how life sciences organizations derive insights and engage with stakeholders, the success of these technologies hinges on more than just sophisticated algorithms. A reliable and interconnected d
A radiologist's hands adjusting MRI settings in a dimly lit imaging room with a breast scan on display.

Jul 14, 2026

Quibim launches CE and UKCA-marked QP-Breast

Quibim has introduced QP-Breast, an innovative AI tool now CE and UKCA-marked, designed to enhance breast cancer detection through magnetic resonance imaging (MRI) in Europe and the UK. This tool is significant as it is the first of its kind in these regions, automatically identifying suspicious lesions during breast MRI assessments.QP-Breast aims to support radiologists by improving the accuracy of lesion detection and generating concise, user-friendly reports that integrate with existing hospi
A minimalist illustration of a money bag and euro symbol representing venture capital funding.

Jul 14, 2026

European biotech chases record VC funding

European biotech is poised for a record year in venture capital (VC) funding, yet significant disparities with the US market persist. As of this year, European biotech startups have attracted approximately €800 million (around $912 million) in investments, which represents a substantial portion of the expected total for 2025. Current trends suggest that the total funding could exceed the previous record of €1.2 billion set in 2018. While the number of funding rounds is projected to increase slig
A pill bottle on a pharmacy counter with a prescription pad in the background.

Jul 14, 2026

China's $110-billion AI pharma boom could redefine the future of medicine

China is rapidly emerging as a leader in pharmaceutical innovation, driven by a significant investment in artificial intelligence, which has led to record-breaking drug deals worth $110 billion in the first half of 2026.The country is shifting from a fast follower to a pioneer in drug discovery, with AI technologies becoming essential for developing next-generation therapies. Currently, China contributes approximately 30% of new drugs in development worldwide, trailing only the United States. Th
A minimalist representation of a network with a central partnership circle.

Jul 14, 2026

EMBL Representative: Lithuania Is Emerging as an Important Partner in Europe’s Life Sciences Network

Collaboration in science is increasingly recognized as essential for addressing complex challenges, as highlighted by Plamena Markova, Chief of International Relations at the European Molecular Biology Laboratory (EMBL). She emphasizes that scientific breakthroughs often stem from decades of partnerships rather than isolated efforts.Markova, who has been with EMBL for over 15 years, underscores the importance of international collaboration in the life sciences. She notes that EMBL's mission is t
A minimalist illustration of a mosquito and a blood drop representing malaria diagnostics.

Jul 14, 2026

Noul's miLab MAL highlighted as leading AI malaria diagnostic in Harvard-led international study

Noul's miLab MAL has been recognized as a leading AI-driven diagnostic tool for malaria in a recent review published by a Harvard-led international research team.The study, featured in "npj Digital Medicine," highlights the effectiveness of Noul's miLab MAL in the context of the global malaria diagnostic landscape. Researchers employed a scoping review methodology, examining both traditional diagnostic methods like microscopy and PCR, alongside emerging AI technologies. This comprehensive approa